These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25091672)

  • 1. Insights from global data for use of rotavirus vaccines in India.
    Rao TS; Arora R; Khera A; Tate JE; Parashar U; Kang G;
    Vaccine; 2014 Aug; 32 Suppl 1():A171-8. PubMed ID: 25091672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus disease and vaccines in India: a tremendous public health opportunity.
    Tate JE; Arora R; Bhan MK; Yewale V; Parashar UD; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():vii-xii. PubMed ID: 25091690
    [No Abstract]   [Full Text] [Related]  

  • 3. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
    Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
    Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesizing evidences for policy translation: a public health discourse on rotavirus vaccine in India.
    Panda S; Das A; Samanta S
    Vaccine; 2014 Aug; 32 Suppl 1():A162-70. PubMed ID: 25091671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
    Rheingans R; Atherly D; Anderson J
    Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
    Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
    Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccines at the threshold of implementation in India.
    Tate JE; Arora R; Kang G; Parashar UD
    Natl Med J India; 2014; 27(5):245-8. PubMed ID: 26037421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
    Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F
    Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities.
    Rheingans R; Anderson JD; Anderson B; Chakraborty P; Atherly D; Pindolia D
    Vaccine; 2014 Aug; 32 Suppl 1():A140-50. PubMed ID: 25091669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
    Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
    Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines.
    Widdowson MA; Steele D; Vojdani J; Wecker J; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S1-8. PubMed ID: 19817589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
    Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus gastroenteritis in India, 2011-2013: revised estimates of disease burden and potential impact of vaccines.
    John J; Sarkar R; Muliyil J; Bhandari N; Bhan MK; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A5-9. PubMed ID: 25091681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health and economic impact of rotavirus vaccination in GAVI-eligible countries.
    Kim SY; Sweet S; Slichter D; Goldie SJ
    BMC Public Health; 2010 May; 10():253. PubMed ID: 20470426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
    J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
    Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
    Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece.
    Syriopoulou V; Kafetzis D; Theodoridou M; Syrogiannopoulos GA; Mantagos S; Trimis G; Mavrikou M; Konstantopoulos A
    Acta Paediatr; 2011 May; 100(5):732-9. PubMed ID: 21223372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account.
    Suwantika AA; Tu HA; Postma MJ
    Vaccine; 2013 Jul; 31(32):3300-7. PubMed ID: 23707163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.